1458 related articles for article (PubMed ID: 19636003)
61. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).
Ay C; Simanek R; Vormittag R; Dunkler D; Alguel G; Koder S; Kornek G; Marosi C; Wagner O; Zielinski C; Pabinger I
Blood; 2008 Oct; 112(7):2703-8. PubMed ID: 18539899
[TBL] [Abstract][Full Text] [Related]
62. Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial.
Christersson C; Oldgren J; Bylock A; Siegbahn A; Wallentin L
Eur Heart J; 2007 Mar; 28(6):692-8. PubMed ID: 17314111
[TBL] [Abstract][Full Text] [Related]
63. Haemostatic complications in haemodialysis patients: effect of type of vascular access and dialysis filter.
Yu A; Egberg N; Jacobson SH
Scand J Clin Lab Invest; 2003; 63(2):127-33. PubMed ID: 12751694
[TBL] [Abstract][Full Text] [Related]
64. Prognostic significance of elevated D-dimer for survival in patients with sarcoma.
Raj SD; Zhou X; Bueso-Ramos CE; Ravi V; Patel S; Benjamin RS; Vadhan-Raj S
Am J Clin Oncol; 2012 Oct; 35(5):462-7. PubMed ID: 21654313
[TBL] [Abstract][Full Text] [Related]
65. D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.
Cosmi B; Legnani C; Cini M; Favaretto E; Palareti G
Thromb Res; 2008; 122(5):610-7. PubMed ID: 18304616
[TBL] [Abstract][Full Text] [Related]
66. Incidence and risk factors for venous thromboembolism in critically ill children after trauma.
Hanson SJ; Punzalan RC; Greenup RA; Liu H; Sato TT; Havens PL
J Trauma; 2010 Jan; 68(1):52-6. PubMed ID: 20065757
[TBL] [Abstract][Full Text] [Related]
67. The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study).
Ageno W; Cosmi B; Ghirarduzzi A; Santoro R; Bucherini E; Poli D; Prisco D; Alatri A; Pengo V; Galli L; Dentali F; Palareti G
Am J Hematol; 2012 Jul; 87(7):713-5. PubMed ID: 22488507
[TBL] [Abstract][Full Text] [Related]
68. Predicting the risk of recurrent venous thromboembolism. The Austrian study on recurrent venous thromboembolism (AUREC).
Kyrle PA; Eischer L
Hamostaseologie; 2013 Aug; 33(3):201-9. PubMed ID: 23712242
[TBL] [Abstract][Full Text] [Related]
69. Need for inferior vena cava filters in cancer patients: a surrogate marker for poor outcome.
Barginear MF; Lesser M; Akerman ML; Strakhan M; Shapira I; Bradley T; Budman DR
Clin Appl Thromb Hemost; 2009; 15(3):263-9. PubMed ID: 18385149
[TBL] [Abstract][Full Text] [Related]
70. Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS).
Königsbrügge O; Pabinger I; Ay C
Thromb Res; 2014 May; 133 Suppl 2():S39-43. PubMed ID: 24862144
[TBL] [Abstract][Full Text] [Related]
71. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors.
Wun T; White RH
Cancer Invest; 2009; 27 Suppl 1():63-74. PubMed ID: 19291526
[TBL] [Abstract][Full Text] [Related]
72. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.
Ota S; Wada H; Abe Y; Yamada E; Sakaguchi A; Nishioka J; Hatada T; Ishikura K; Yamada N; Sudo A; Uchida A; Nobori T
Clin Appl Thromb Hemost; 2008 Jul; 14(3):279-85. PubMed ID: 18160575
[TBL] [Abstract][Full Text] [Related]
73. The VIDAS D-dimer test for venous thromboembolism: a prospective surveillance study shows maintenance of sensitivity and specificity when used in normal clinical practice.
Mountain D; Jacobs I; Haig A
Am J Emerg Med; 2007 May; 25(4):464-71. PubMed ID: 17499668
[TBL] [Abstract][Full Text] [Related]
74. Effect of selected prothrombotic and proinflammatory factors on the incidence of venous thrombosis after pacemaker implantation.
Lelakowski J; Domagała TB; Rydlewska A; Januszek R; Kotula Horowitz K; Majewski J; Ząbek A; Małecka B; Musiał J
Kardiol Pol; 2012; 70(3):260-7. PubMed ID: 22430407
[TBL] [Abstract][Full Text] [Related]
75. Elevated D-dimers are also a marker of underlying malignancy and increased mortality in the absence of venous thromboembolism.
Knowlson L; Bacchu S; Paneesha S; McManus A; Randall K; Rose P
J Clin Pathol; 2010 Sep; 63(9):818-22. PubMed ID: 20671046
[TBL] [Abstract][Full Text] [Related]
76. Diagnosis and initial treatment of venous thromboembolism in patients with cancer.
Streiff MB
J Clin Oncol; 2009 Oct; 27(29):4889-94. PubMed ID: 19738109
[TBL] [Abstract][Full Text] [Related]
77. The predictive characteristics of D-dimer testing in outpatients with suspected venous thromboembolism: a Bayesian approach.
Risch L; Monn A; Lüthy R; Honegger H; Huber AR
Clin Chim Acta; 2004 Jul; 345(1-2):79-87. PubMed ID: 15193980
[TBL] [Abstract][Full Text] [Related]
78. [Frequency of venous thromboembolism among hospitalized patients with cancer].
Conte G; Figueroa G
Rev Med Chil; 2008 Dec; 136(12):1528-34. PubMed ID: 19350169
[TBL] [Abstract][Full Text] [Related]
79. [Estimation of venous thromboembolism risk with thrombotic biomarkers in cancer patients].
Jianlong M; Diansheng Z; Jing R
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):283-9. PubMed ID: 26462893
[TBL] [Abstract][Full Text] [Related]
80. Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS).
Posch F; Thaler J; Zlabinger GJ; Königsbrügge O; Koder S; Zielinski C; Pabinger I; Ay C
Clin Cancer Res; 2016 Jan; 22(1):200-6. PubMed ID: 26302981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
